The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $94.16

Today's change-1.45 -1.52%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $94.16

Today's change-1.45 -1.52%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc down (U.S.)$1.45

Abiomed Inc closed sharply lower Thursday, dropping (U.S.)$1.45 or 1.52% to (U.S.)$94.16. Shares have lost 4.11% over the last five days, but have gained 147.40% over the last year to date. This security has outperformed the S&P 500 by 273.48% during the last year.

Key company metrics

  • Open(U.S.) $96.05
  • Previous close(U.S.) $95.61
  • High(U.S.) $97.98
  • Low(U.S.) $93.80
  • Bid / Ask-- / --
  • YTD % change+147.40%
  • Volume563,852
  • Average volume (10-day)791,176
  • Average volume (1-month)1,086,055
  • Average volume (3-month)750,448
  • 52-week range(U.S.) $21.84 to (U.S.) $110.68
  • Beta1.23
  • Trailing P/E33.47×
  • P/E 1 year forward128.09×
  • Forward PEG7.25×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.81
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.38%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue73686252
Total other revenue--------
Total revenue73686252
Gross profit63575242
Total cost of revenue11111010
Total operating expense58554848
Selling / general / administrative37353029
Research & development101089
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income1512144
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1512144
Income after tax999134
Income tax, total6-8710
Net income999134
Total adjustments to net income--------
Net income before extra. items999134
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items999134
Inc. avail. to common incl. extra. items999134
Diluted net income999134
Dilution adjustment--------
Diluted weighted average shares44444342
Diluted EPS excluding extraordinary itemsvalue per share0.202.230.300.09
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.202.230.300.09